FDA Warning Letter — Ampride
The FDA took a Warning Letter action against Ampride on Nov 16, 2017 (Herington, KS). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- Ampride
- Date
- Nov 16, 2017
- Fiscal Year
- 2018
- Product Type
- Tobacco
- Center
- CTP
- Location
- Herington, KS (United States)